EdgeMarket › What Nantahala Capital Management, Llc reported owning
What Nantahala Capital Management, Llc reported owning
As filed on Form 13F for the quarter ending 2026-03-31, up to 45 days after that date. Long-only US-listed equity — shorts, bonds, cash and non-US listings are not on the form, so this is one leg of the book, not the book.
Reported value
2.7BPositions
152Quarter
2026-03-31Shown below
50largest by value
| holding | value | % of book | shares | price | 1y |
|---|---|---|---|---|---|
| TBBK Bancorp, Inc. | 74.2M | 2.7% | 1.4M | 67.19 | +1.1% |
| HGV Hilton Grand Vacations Inc. | 59.2M | 2.2% | 1.5M | 45.11 | +3.4% |
| unmapped CUSIP 834203309 | 58.4M | 2.1% | 1.7M | — | — |
| BVS Bioventus Inc. | 55.9M | 2.1% | 6.1M | 14.38 | +99.4% |
| PTON PELOTON INTERACTIVE, INC. | 51.5M | 1.9% | 12.0M | 5.41 | -30.0% |
| ESTA ESTABLISHMENT LABS HOLDINGS INC. | 47.3M | 1.7% | 833.0K | 72.67 | +85.9% |
| SVRA Savara Inc | 40.1M | 1.5% | 7.3M | 5.59 | +80.9% |
| XTNT Xtant Medical Holdings, Inc. | 38.2M | 1.4% | 68.4M | 0.32 | -46.9% |
| GOGO Gogo Inc. | 35.7M | 1.3% | 8.9M | 2.68 | -78.2% |
| AMRX Amneal Pharmaceuticals, Inc. | 35.4M | 1.3% | 2.8M | 17.91 | +90.3% |
| AVR Anteris Technologies Global Corp. | 30.7M | 1.1% | 5.5M | 8.98 | +152.2% |
| ETON Eton Pharmaceuticals, Inc. | 29.0M | 1.1% | 1.2M | 63.47 | +283.5% |
| EOLS Evolus, Inc. | 26.2M | 1.0% | 6.4M | 8.39 | +16.0% |
| TNGX Tango Therapeutics, Inc. | 26.2M | 1.0% | 1.3M | 23.88 | +253.8% |
| LBRX LB PHARMACEUTICALS INC | 26.0M | 1.0% | 1.1M | 47.62 | — |
| FOXF FOX FACTORY HOLDING CORP | 24.5M | 0.9% | 1.5M | 21.85 | -24.4% |
| MLYS Mineralys Therapeutics, Inc. | 24.3M | 0.9% | 895.5K | 25.65 | +65.7% |
| ZVRA ZEVRA THERAPEUTICS, INC. | 23.5M | 0.9% | 2.5M | 11.87 | +27.9% |
| FULC Fulcrum Therapeutics, Inc. | 23.4M | 0.9% | 3.1M | 3.83 | -41.7% |
| FOSL Fossil Group, Inc. | 23.3M | 0.9% | 5.4M | 5.61 | +89.5% |
| RDNW RideNow Group, Inc. | 23.1M | 0.9% | 3.3M | 5.97 | +85.4% |
| ABEO ABEONA THERAPEUTICS INC. | 22.5M | 0.8% | 5.0M | 6.09 | -13.0% |
| CWH Camping World Holdings, Inc. | 22.3M | 0.8% | 3.3M | 6.54 | -62.2% |
| ADCT ADC Therapeutics SA | 21.0M | 0.8% | 5.6M | 1.00 | -68.0% |
| TITN Titan Machinery Inc. | 21.0M | 0.8% | 1.3M | 20.18 | +3.6% |
| HLF HERBALIFE LTD. | 19.9M | 0.7% | 1.4M | 12.65 | +34.4% |
| IMAX IMAX CORP | 19.6M | 0.7% | 515.6K | 52.74 | +104.8% |
| VSTM Verastem, Inc. | 19.0M | 0.7% | 3.6M | 6.89 | -17.2% |
| BCRX BIOCRYST PHARMACEUTICALS INC | 18.9M | 0.7% | 2.0M | 9.55 | +14.0% |
| AVTX Avalo Therapeutics, Inc. | 18.4M | 0.7% | 1.2M | 19.83 | +115.1% |
| RMR RMR GROUP INC. | 17.8M | 0.7% | 1.1M | 20.00 | +22.9% |
| RYAM RAYONIER ADVANCED MATERIALS INC. | 17.7M | 0.7% | 1.6M | 8.66 | +73.2% |
| GERN GERON CORP | 16.7M | 0.6% | 11.2M | 1.52 | +9.4% |
| BNTC Benitec Biopharma Inc. | 15.3M | 0.6% | 1.4M | 13.48 | +4.7% |
| ABVX Abivax S.A. | 15.3M | 0.6% | 137.2K | 114.95 | +59.9% |
| ITGR Integer Holdings Corp | 15.1M | 0.6% | 172.0K | 125.20 | +16.7% |
| KROS Keros Therapeutics, Inc. | 15.0M | 0.6% | 1.4M | 11.03 | -22.5% |
| JACK JACK IN THE BOX INC | 14.9M | 0.5% | 1.5M | 17.24 | -7.7% |
| JCAP Jefferson Capital, Inc. / DE | 14.4M | 0.5% | 750.0K | 22.29 | +24.1% |
| AURA Aura Biosciences, Inc. | 14.2M | 0.5% | 2.1M | 7.80 | +22.4% |
| USNA USANA HEALTH SCIENCES INC | 14.2M | 0.5% | 810.1K | 13.55 | -56.5% |
| PCVX Vaxcyte, Inc. | 13.9M | 0.5% | 238.7K | 62.62 | +100.3% |
| MDXG MIMEDX GROUP, INC. | 13.4M | 0.5% | 3.4M | 4.33 | -39.6% |
| unmapped CUSIP 04546C304 | 13.2M | 0.5% | 692.3K | — | — |
| DSGR Distribution Solutions Group, Inc. | 13.0M | 0.5% | 494.6K | 34.80 | +9.2% |
| AGMB Agomab Therapeutics NV | 12.9M | 0.5% | 1.2M | 13.25 | — |
| HLXC Helix Acquisition Corp. III | 12.7M | 0.5% | 1.2M | 10.93 | — |
| APYX Apyx Medical Corp | 12.7M | 0.5% | 3.4M | 3.12 | +53.7% |
| SLN Silence Therapeutics plc | 11.3M | 0.4% | 2.1M | 13.27 | +149.0% |
| JANX Janux Therapeutics, Inc. | 11.3M | 0.4% | 809.9K | 17.39 | -30.1% |
A position that grew quarter on quarter may simply reflect a higher price: if the stock rose 40% and the manager did nothing, the reported value rose 40%. Reading that as accumulation is reading the price back to yourself. More on that →
The whole archive is one click away.
Screener, filings, insider flow, backtests and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →